Talazoparib was approved for the treatment of breast cancer. However, the safety of talazoparib in a large population sample over an extended period remained uncertain. The objective of this study is to offer guidance for the secure utilization of talazoparib in clinical settings.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2024) studied this question.